Australia's Proteomics International up after signing licensing agreement
** Shares of Proteomics International Laboratories Ltd
PIQ.AX rise as much as 25% to A$1.125, hitting their highest
since March 27
** Stock set to mark best day since Feb.8, if gains hold
** Medical technology co signs an exclusive licence
agreement with Sonic Healthcare USA, a division of Sonic
Healthcare Ltd
** Says agreement is for the use and commercialisation of
the company's PromarkerD test for diabetic kidney disease in the
United States
** PIQ has fallen 5.3% this year, as of last close
(Reporting by Nausheen Thusoo in Bengaluru)
((Nausheen.Thusoo@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius